Sarah A Cook

10PUBLICATIONS
80CO-AUTHORS
Molecular targetsPredictive and prognostic markersPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 28, 2025
FOLR1 as a therapeutic target in platinum-resistant ovarian carcinoma: unique expression patterns across ovarian carcinoma histotypes and molecular subtypes of low-grade serous carcinoma.

Yuen Yee Leung, Marta Llaurado-Fernandez, Anna Cameron

|Jun 26, 2023
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study.

Ana Oaknin, Bhavana Pothuri, Lucy Gilbert

|Jun 06, 2023
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.

Todd M Bauer, Kathleen N Moore, Janet S Rader

|Mar 23, 2023
A rapidly evolving landscape: immune checkpoint inhibitors in pretreated metastatic endometrial cancer.

Anna V Tinker, Neesha C Dhani, Prafull Ghatage

|Mar 06, 2023
Fighting resistance: post-PARP inhibitor treatment strategies in ovarian cancer.

Ana C Veneziani, Clare Scott, Matthew J Wakefield

|Oct 20, 2022
Germline Testing and Somatic Tumor Testing for BRCA1/2 Pathogenic Variants in Ovarian Cancer: What Is the Optimal Sequence of Testing?

Janice S Kwon, Anna V Tinker, Jennifer Santos

Pageof 2

Frequent Collaborators

3 joint publications

Stefan Kommoss

3 joint publications

Martin Koebel

2 joint publications

Pauline Krämer

2 joint publications

Peter Lim